共 21 条
[1]
Fugh-Berman, Epstein, Tamoxifen: disease prevention or disease substitution?, Lancet, 340, pp. 1143-1145, (1992)
[2]
Farinati, De Maria, Fornasiero, Salvagnini, Fagiuoli, Chiaramonte, Vaccarato, Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma, Dig Dis Sci, 37, pp. 659-662, (1992)
[3]
Boix, Bruix, Castells, Fuster, Bru, Visa, Rivera, Rodes, Sex hormone receptors in hepatocellular carcinoma. Is there a rationale for hormonal treatment?, J Hepatol, 17, pp. 187-191, (1993)
[4]
Davidson, Tamoxifen - panacea or Pandora's box?, N Engl J Med, 326, pp. 885-886, (1992)
[5]
Pavlidis, Petris, Briassoulis, Klouvas, Psilas, Rempapis, Petroutsos, Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients, Cancer, 69, pp. 2961-2964, (1992)
[6]
Ron, Inbar, Barak, Stier, Chaitchik, Organic delusional syndrome associated with tamoxifen treatment, Cancer, 69, pp. 1415-1417, (1992)
[7]
Nayfield, Karp, Ford, Dorr, Kramer, Potential role of tamoxifen in prevention of breast cancer, J Natl Cancer Inst, 83, pp. 1450-1459, (1991)
[8]
Loomus, Aneia, Bota, A case of peliosis hepatis in association with tamoxifen therapy, Am J Clin Pathol, 80, pp. 881-883, (1983)
[9]
Blackburn, Amiel, Millis, Rubens, Tamoxifen and liver damage, BMJ, 289, (1984)
[10]
Ludwig, Practica liver Biopsy Interpretation - Diagnostic Algorithms, (1992)